ArticleMolecular genetics and metabolism2020
Gaucher disease and SARS-CoV-2 infection: Emerging management challenges.
Article in Molecular genetics and metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Review
- Expert-opinion-based guidance for the care of children with lysosomal storage diseases during the COVID-19 pandemic: An experience-based Turkey perspective.Frontiers in public health · 2023Review
- Physiologically-Based Pharmacokinetic Model Development, Validation, and Application for Prediction of Eliglustat Drug-Drug Interactions.Clinical pharmacology and therapeutics · 2022Article
- Real-world patient data on immunity and COVID-19 status of patients with MPS, Gaucher, and Pompe diseases from Turkey.Archives de pediatrie : organe officiel de la Societe francaise de pediatrie · 2022Article
- The clinical spectrum of SARS-CoV-2 infection in Gaucher disease: Effect of both a pandemic and a rare disease that disrupts the immune system.Molecular genetics and metabolism · 2022Observational
- Toll-Like Receptor 4 ExacerbatesContrast media & molecular imaging · 2022Article
- Experts' views on COVID-19 vaccination and the impact of the pandemic on patients with Gaucher disease.British journal of haematology · 2021Article
- Current and emerging pharmacotherapy for Gaucher disease in pediatric populations.Expert opinion on pharmacotherapy · 2021Article
- Gaucher disease in the COVID-19 pandemic environment: The good, the bad and the unknown.Molecular genetics and metabolism · 2021Article
- Gaucher disease and SARS-CoV-2 infection: Experience from 181 patients in New York.Molecular genetics and metabolism · 2021Article
- A case with Gaucher disease unable to reach enzyme replacement therapy because of COVID-19 quarantine: The first case from Turkey.Turkish archives of pediatrics · 2021Article
- COVID-19 impact on the diagnosis of Inborn Errors of Metabolism: Data from a reference center in Brazil.Genetics and molecular biology · 2021Article
- The impact of COVID-19 pandemic on the diagnosis and management of inborn errors of metabolism: A global perspective.Molecular genetics and metabolism · 2020Article
- Direct and indirect effects of the SARS-CoV-2 pandemic on Gaucher Disease patients in Spain: Time to reconsider home-based therapies?Blood cells, molecules & diseases · 2020Article
- SARS-CoV-2 infection in a patient with propionic acidemia.Orphanet journal of rare diseases · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.